Z Cermakova
Overview
Explore the profile of Z Cermakova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bunganic R, Blahutova S, Revendova K, Zapletalova O, Hradilek P, Hrdlickova R, et al.
Sci Rep
. 2022 Nov;
12(1):18374.
PMID: 36319704
An evidence-based treatment for a Multiple Sclerosis (MS) relapse is an intravenous administration of 3-5 g of Methylprednisolone. In case of insufficient effect or corticosteroids intolerance, the therapeutic plasma exchange...
2.
Maluskova A, Mrazek F, Kozelska R, Koristka M, Cermakova Z
Bratisl Lek Listy
. 2021 Feb;
122(3):179-183.
PMID: 33618525
Aim: It remains unclear, why only some patients form alloantibodies against foreign RBC antigens. Transfusion of red blood cell (RBC) products and pregnancy are the most relevant causes of immunization...
3.
Cvek J, Knybel L, Stransky J, Matousek P, Res O, Zelenik K, et al.
Klin Onkol
. 2017 Aug;
30(4):282-288.
PMID: 28832174
Aim: The aim of this study was to evaluate overall survival (OS) and prognostic factors in patients ineligible for chemotherapy who were treated with a hyperfractionated accelerated schedule with simultaneous...
4.
Jelinek T, Koristka M, Cermakova Z, Hajek R
Klin Onkol
. 2017 Feb;
30(1):13-19.
PMID: 28185460
Monoclonal antibodies represent a standard part in the treatment of oncologic patients, but their efficacy in multiple myeloma used to be unsatisfactory. Daratumumab monotherapy was approved by the American FDA...
5.
Maluskova A, Mrazek F, Pauliskova M, Kovarova P, Koristka M, Jindra P, et al.
Vox Sang
. 2017 Jan;
112(2):156-162.
PMID: 28052334
Background And Objectives: Alloimmune antibodies against red-blood-cell (RBC) antigens induced in susceptible individuals (responders) by transfusion, pregnancy or transplantation may have serious clinical consequences. The aim of this study was...
6.
Krbkova L, Bednarova J, Cermakova Z
Epidemiol Mikrobiol Imunol
. 2016 Jul;
65(2):112-7.
PMID: 27467328
Background: The purpose of the study was to evaluate new 3rd-generation test kits, EIA Borrelia recombinant IgM and IgG (TestLine, Brno, Czech Republic), in serum and cerebrospinal fluid (CSF) of...
7.
Krbkova L, Homola L, Hlavacova A, Mikolasek P, Bednarova J, Cermakova Z
Epidemiol Infect
. 2016 May;
144(12):2597-604.
PMID: 27180603
To examine evidence of positive antibodies against immunogenic proteins of Anaplasma phagocytophilum in patients with other tick-borne infections and to diagnose possible co-infections, 412 serum specimens were tested by immunoblotting...
8.
Eid M, Szturz P, Cermakova Z, Adam Z, Mayer J
Klin Onkol
. 2014 Aug;
27(3):221-2.
PMID: 25147881
No abstract available.
9.
Polak P, Sevcikova A, Stroblova H, Cermakova Z, Husa P
Klin Mikrobiol Infekc Lek
. 2014 Jun;
20(1):15-7.
PMID: 24960259
Ocular complications are very frequent in leptospirosis and may develop in both the acute (bacteriemic) and the second (immunologic) phases of the disease. A delayed onset of these complications, even...
10.
Szturz P, Sediva A, Zurek M, Adam Z, Stork J, Cermakova Z, et al.
Klin Onkol
. 2014 Apr;
27(2):111-26.
PMID: 24739048
Background: Schnitzler syndrome is a very rare, acquired, autoinflammatory disease of mostly adult onset with characteristic combination of chronic recurrent urticaria and monoclonal immunoglobulin M or G gammopathy predisposing the...